The vision of the 2013 Women's Career and Leadership Development Conference for Women Cardiologists and Cardiothoracic Surgeons is to diversify the cardiology and cardiothoracic field by creating a vibrant community of women cardiologists and cardiothoracic surgeons that will strengthen their non-clinical professional skills, provide opportunities to enhance their professional standing, and encourage them to assume leadership positions in the field and within the American College of Cardiology.

This is the 8th year for the International Symposium on Ventricular Arrhythmias: Pathophysiology and Therapy. Using a combination of didactic presentations, panel discussions, and questions and answer sessions, our goal is to educate the participants on state-of-the-art information pertaining to the pathophysiology and treatment of ventricular arrhythmias. There will also be VT related cases streamed live from the University of Pennsylvania during which a moderated panel discussion and question and answer session will occur to educate and demonstrate to the audience members the most up to date techniques for complex ablation and other procedures.

This course is designed to provide the learner with the most up-to-date review of lead management and to give an in-depth review of indications for lead extraction and management of device infections as well as available tools and technology for extraction. A live extraction case will be featured, followed by a panel discussion by experts in the field.

Program faculty will review detailed illustrative cases with a step-by-step analysis, providing a current, in-depth review of approaches to catheter ablation for the spectrum of cardiac arrhythmias including atrial fibrillation, complex atrial arrhythmias after AF ablation or in congenital heart disease, atrial tachycardia’s and atypical flutters, and ventricular arrhythmias with or without associated heart disease.

Innovating, Translating and Integrating Clinical Care in Electrophysiology presents evidence-based strategies that will impact your practice performance and improve outcomes for your patients with cardiovascular disease. The expert faculty will provide insights and opinions on methods for treating refractory heart failure, genetically determined arrhythmias and atrial fibrillation in an integrated, multi-specialty program.

The 16th Annual New Frontiers in Heart Failure Therapy® meeting scheduled for January 23rd was cancelled due to Winter Storm Jonas. This meeting has been rescheduled and will now take place on the afternoon of May 14, 2016. The 24th Update on Arrhythmia Diagnosis and Management® meeting will take place, as originally scheduled, on the morning of May 14. The Arrhythmia Diagnosis and Management course will examine important issues pertaining to integrating advances in treatment and technology into clinical practice. The New Frontiers in Heart Failure Therapy course will address the compelling evidence for aggressive medical and device-based therapies for patients with chronic heart failure.

Through a program of lectures from world experts and participant-faculty interactions, attendees will learn the most up-to-date approaches to the management of various cardiac rhythm disorders, including arrhythmia syndromes, VT, device implantation, and AF rhythm and anticoagulation drug therapy. The faculty will discuss recent data, challenges, and implications for clinical practice in diagnosing and treating these disorders. After completing this activity, participants will return to their practice environment armed with the latest evidence-based, practical information to improve patient outcomes.

This symposium is a multi-specialty cardiovascular educational symposium in North America on the frontier science of left atrial appendage. This topic is of tremendous interest in the practice of cardiovascular care. Over a period of two days, the symposium will offer very informative presentations on the anatomy, physiology, and pathological aspects of the left atrial appendage, along with old and new therapeutic strategies of stroke prophylaxis, including cardiac devices for LAA exclusion. Presenting will be the leaders in the field with a great depth of practical expertise in the science from across the world. This symposium will address gaps in knowledge and competence through didactic lectures, panel discussions, debates, and discussion of live case studies.

The AF VT VF Summit presents the latest results of basic and clinical research and information about ablation, imaging technologies and device therapies. The symposium will provide illustrated oral presentations, pre-recorded live cases by national international experts, as well as discussion of latest guidelines. It is designed to help foment changes in practice relative to arrhythmia management.

By far, the Global CardioVascular Clinical Trialists (CVCT) Forum, now in its 13th year, provides the best annual update and in-depth understanding of the trials shaping the evidence base of modern cardiology.

Join academics, trialists, regulators, R&D experts, and young investigators for an interactive exchange covering all areas of CV trials. CVCT Forum is the only event focusing specifically on clinical trials in cardiovascular disease that brings together key decision makers, conceivers of clinical trial protocols, investigators, regulatory authorities, clinical research associations, cardiologists, general practitioners, epidemiologists, and industry.

Attendees of the symposium will gain an understanding of novel molecular diagnostics for risk stratification of sudden cardiac death, diagnostic and treatment protocols for special populations of patients including athletes and pregnant patients as well as new therapies in cardiac ablation, surgical intervention, and cardiac device management for patients with congestive heart failure, atrial fibrillation and ventricular tachycardia.

Physicians and other providers are constantly faced with evolving techniques and tools for diagnosing and treating arrhythmia patients. Rapid change and new research make it difficult to ensure that electrophysiology-related diagnosis and treatment is consistent with the most current guidelines. Primary care physicians encounter patients with arrhythmia symptoms, heart failure, and syncope and must determine if patients are at risk of life-threatening arrhythmias and whether they may benefit from a cardiology or electrophysiology referral. Recent studies have shown a general lack of familiarity among healthcare professionals with current implantable cardioverter defibrillator implantation clinical guidelines; an even larger knowledge gap exists in this area among primary care physicians. This lack of familiarity with clinical guidelines highlights the need to improve diagnostic competence and treatment knowledge among all healthcare professionals who care for arrhythmia patients.

Stanford Biodesign New Arrhythmia Technologies Retreat will highlight the latest and emerging technologies in arrhythmia therapy. The Retreat is designed to serve as an expert forum of key thought leaders and innovators to share their ideas about new and emerging technologies in arrhythmia management and diagnosis. Physicians and scientists will be asked to give brief talks about the emerging developments in their field, the key needs in cardiac arrhythmias in their area of expertise, and the likely solutions in the next 5 years. A speed-dating format will be used to highlight start-up companies in the field. Start-up innovators will be given the opportunity to speak about the start-up and medical device innovation process.

CardioRhythm 2017 will to be held February 24–26, 2017 in Hong Kong. The Conference is jointly organized by the Hong Kong College of Cardiology and Chinese Society of Pacing and Electrophysiology.

CardioRhythm 2017 will provide an excellent opportunity for you to stay abreast of the latest developments in the field of cardiac rhythm management. Lectures, case presentations and workshops focusing on sudden cardiac death, new drug and ablation treatment for atrial fibrillation, pacing and ICD advances, cardiac resynchronization techniques, remote patient monitoring, and advances in neuromodulation for heart failure and hypertension will be presented by experts from around the world.

The Duke Sports Cardiology and Sudden Death in Athletes Symposium has been designed to enhance learners’ knowledge and their competency to incorporate evidence-based updates in the care of athletes in order to mitigate their risk for sudden cardiac death (SCD).

Other topics will include evaluating the unique characteristics of an athlete’s heart, prescribing appropriate testing strategies and effectively interpreting test results, as well as the pros and cons of using EKG screening in athletes. In addition to case presentations by Duke faculty and fellows, effective training in and implementation of evidence-based resuscitation strategies, rapid response, and the use of automated external defibrillators (AEDs), will also be reviewed.

The symposium format will include lectures, panel discussions and case studies, and will be relaxed and interactive.

The Heart Rhythm Society is hosting a China Summit on "Contemporary Management of Arrhythmias", 7 April, 2017 from 08:30 – 17:00. In cooperation with the Asia Pacific Heart Rhythm Society and the Chinese Society of Pacing and Electrophysiology, this Summit is being held in conjunction with the APHRS Leadership Summit and the Arrhythmia Symposium 7-8 April, 2017.

The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology (EP), and on new diagnosis and treatment guidelines in the care and management of patients with arrhythmias, heart failure, and other issues impacting the electrical system of the body. Participants will learn about advances in ablation techniques, device management, appropriate use criteria, and survey new developments in guidelines and recommendations. A review of clinical trials that have helped change the clinical practice of EP will also be held. Participants in this symposium will examine the latest trends in Left Atrial Appendage (LAA) treatment options and gain a greater understanding of anticoagulation and stroke prophylaxis.

The purpose of this symposium is to bring together physicians and healthcare professionals to engage in a multi-disciplinary program to address the current standards and advances in identifying and optimally treating atrial fibrillation. Our program will provide important details from the latest findings in research and a unique hands-on opportunity to explore state-of-the-art techniques and technologies. Case presentations, short lectures on finite subjects, followed by interactive discussions and simulation demonstrations will be offered from an esteemed lineup of physician experts. We are proud to offer additional training options through our cadaveric mobile lab, located on-site.

The Conference is jointly provided by Charlotte Area Health Education Center, Carolinas HealthCare System, CaroMont Health, and Novant Health. This inaugural conference will bring to the forefront the emerging technologies and treatment strategies for Electrophysiology (EP) and heart failure patient populations.  Experts in the field of cardiac care management and electrophysiology will present on a variety of topics. Breakout session tracks will allow those interested in devices, EP lab, and clinical care to attend sessions  relevant to their interests and specialties.

<br><br>Continuing education credit will be provided for nurses and physician assistants. Applications will be made for AARC-CRCE credit for Respiratory Therapists and for AART credit for Radiology Techs.

This one-day program is designed to provide clinicians with a review of selected topics in present day management of patients withe cardiac arrhythmias, emphasizing new advances in the field, and incorporating current guidelines and evidence-based principles of practice. The format will incorporate didactic lectures as well as case management studies and panel discussions with experts in the field.

This program is designed to provide electrophysiologists, cardiologists, internists, and associated professionals with state of the art information on invasive and non-invasive electrocardiographic and electrophysiologic tools used in the diagnosis, evaluation, and treatment of cardiac rhythm disorders. Attendees of the symposium will develop an understanding of the correct approach to the patients with atrial fibrillation, other atrial ventricular tachycardias and risk factors for sudden death.

The Colorado Arrhythmia Symposium 2017 annual conference is a 3-day educational program focusing on advanced electrophysiology concepts and new developments in clinical strategies to treat arrhythmias. Participants learn from the conference faculty through didactic lectures, case presentations, debates, and informal discussions.

This course is designed to teach lead extraction. Background anatomy, pathophysiology, pacing, and ICD lead construction will all be reviewed in their importance of when and how to perform lead extraction. The process of lead extraction including technique, safety and staff, equipment, and facility requirements will be taught. Teaching techniques will include case studies, anatomical examples, and pacing/defribrillating lead. The full day symposium will include morning didactic lecture and afternoon workshops for specialized lectures, case-based studies, anatomy specimens, hands-on using lead extraction tools, and recorded cases.

The meeting will focus on all the aspects of cardiac arrhythmias, from epidemiology, to pathophysiology, natural
history, diagnosis, prognosis and treatment, by over 300 invited speakers, all internationally renowned leaders in the field of clinical arrhythmology, electrophysiology and cardiac pacing.

The main themes of VeniceArrhythmias 2017 will be: Arrhythmogenic hereditary syndromes, arrhythmias in the elderly,
antithrombotic therapy for cardiac arrhythmias, cardiac arrhythmia surgery; to the basics including EP; HF, CRT and more. Special emphasis will be given to the most recent technological developments and innovations, and to complex cases of interventional arrhythmology and live
cases from EP labs.

An important part of the scientific program of VeniceArrhythmias 2017 will be directly prepared by
the most prestigious Scientific Societies operating in the field of cardiac arrhythmias (VA – International Scientific Societies
Joint sessions).

The AATS Surgical Treatment of Arrhythmias and Rhythm Disorders course is a two-day, interactive forum to support the exchange of information between electrophysiologists and surgeons. Providing a comprehensive, unbiased review of the surgical treatment of cardiac arrhythmias and rhythm disorders, the meeting will cover basic underlying mechanisms, cardiac recording and mapping techniques, clinical electrophysiology, operative techniques, cardiac monitoring and appropriate follow-up. The esteemed faculty will cover: interventional approaches to atrial fibrillation, ventricular tachycardia, inappropriate sinus tachycardia, and transvenous and epicardial lead implantation and extraction techniques.

The 1st annual Physiology of Pacing Symposium 2017 is designed to provide clinicians with an in-depth understanding of current methods and strategies to optimize physiological pacing of the heart. This one-day symposium will focus on His-bundle Pacing (HBP), an evolving pacing modality that has the most potential to achieve electrical excitation of the heart through the normal specialized conduction system. Participants will review the history and relevant anatomy of the conduction system with regard to HBP, with particular educational emphasis on tips and methods for successful implantation. The program will then serve to provide an overview of clinical applications that have been established and are currently being evaluated through clinical trials. Comparative clinical and/or surgical strategies to achieve cardiac resynchronization through leadless technology, multi-site pacing, and left ventricular endocardial pacing will be highlighted as well, with emphasis of physiologic considerations.

At ACC’s Cardiovascular Summit you will experience how to effectively align strong leadership with innovative business strategies to fit the puzzle pieces together to ensure better care, smarting spending, healthier people and happier providers. Network with over 400 colleagues across the country while learning from the leading experts in the field of cardiology, business practices and leadership. Immerse yourself in an educational experience that leads to operational excellence, cost efficiency, leadership training and workforce satisfaction during this time of radical care delivery transformation.  

The Rhythm Management Summit will host 70 experienced EP physicians from the Middle East & North Africa regions to bring you talks on guidelines and advancements in devices, electrophysiology, and LAA closure technologies. Three international researchers will be the speakers at the summit, in addition to dedicated lectures for local EP societies to present cases and have an interactive discussions during this event.

This symposium is a multi-specialty Cardiovascular educational symposium in North America on the frontier science of left atrial appendage. This topic is of tremendous interest in the practice of cardiovascular care. Over a period of two days, the symposium will offer very informative presentations on the anatomy, physiology and pathological aspects of the left atrial appendage along with old and new therapeutic strategies of stroke prophylaxis including cardiac devices for LAA exclusion. The worldwide presenters are the leaders in the field with a great depth of practical expertise in the science.

The Western Atrial Fibrillation (WAF) Symposium assembles key global thought leaders for a collaborative discussion regarding the latest advancement in atrial fibrillation research and treatment. WAF features a distinguished faculty of physicians and researchers from 10 countries and 44 renowned biomedical centers across the United States. WAF speakers and panels discuss topics such as the electrical mechanisms of atrial fibrillation, image processing to improve AF management, AF and heart failure, MRI-guided ablation, improvements in patient care and AF outcomes, microscopy to characterize fibrosis, drug therapy, ECG monitoring, and technical advancements in the field of atrial fibrillation.

EP Live 2018


EP Live is a 2-day intensive educational meeting targeting practicing electrophysiologists as well as fellows in training. The meeting consists of four sections: AF ablation, VT ablation, devices and new technologies. In addition, a panel of recognized experts will provide commentary and discussion. Previously recorded cases will also be shown.

The AF VT VF Summit is designed for electrophysiologists, cardiologists, fellows-in-training, and others interested in cardiac arrhythmias. We will present the latest results of basic and clinical research and information about ablation, imaging and device technologies and therapies. This year we will have interactive discussions, case presentations, and panel discussion. New this year: Poster Presentations!

By far, the Global CardioVascular Clinical Trialists Forum (CVCT), now in its 14th year, provides the best annual update and in-depth understanding of the trials shaping the evidence base of modern cardiology.

Join academics, trialists, regulators, R&D experts and young investigators for an interactive exchange covering all areas of CV trials. CVCT Forum is the only event focusing specifically on clinical trials in cardiovascular disease that brings together key decision makers, conceivers of clinical trial protocols, investigators, regulatory authorities, clinical research associations, cardiologists, general practitioners, epidemiologists and industry.

Join Zhang Shu, MD, FHRS and Saibal Kar, MD, FSCAI for a special symposium at Great Wall International Congress of Cardiology. Sponsored by SCAI and endorsed by HRS, “LAA Closure for Stroke Prevention: Patient Selection and Practical Considerations” is a multi-disciplinary, evidence- and case-based symposium designed to provide an overview of all treatment modalities to provide better care to patients.

The purpose of the Annual International Symposium on Ventricular Arrhythmias is to provide a current review of new information on the basic pathophysiology of ventricular arrhythmias; to provide an in-depth understanding of the various management strategies that are currently being developed for the management of ventricular arrhythmias in various disease states, including non-pharmacologic therapies such as an implantable device therapy and advances in catheter ablation techniques.

The International Forum of Arrhythmias’ main focus is to update in mechanisms, diagnosis and treatment of arrhythmias in a collegial atmosphere as interactive as possible and case based if applicable. Sessions on basic clinical electrophysiology will also be provided. The most popular parts of the IFA, Heart Failure Summit and  Atrial Fibrillation Forum will take place this year as well with the contribution of the global leaders in the  field. You are invited to attend the IFA to be part of the latest science. For more information, please visit .